Clover Biopharmaceuticals Ltd.(HK:2197)
HK$1.67-0.04 (-2.63%)
HK:2197
Clover Biopharmaceuticals Ltd. financials statements
HK$1.67
At close:-0.04 (-2.63%)
Want to see HK:2197 full AI Analyst Report?
Clover Biopharmaceuticals Ltd. (2197) Income Statement
1 Followers
Clover Biopharmaceuticals Ltd. Income Statement
Last quarter (Q2 2026), Clover Biopharmaceuticals Ltd.'s total revenue was ¥176.53K, an increase of 101.75% from the same quarter last year. In Q2, Clover Biopharmaceuticals Ltd.'s net income was ¥941.79M. See Clover Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 3.41M | ¥ 38.42M | ¥ 39.26M | ¥ 0.00 | ¥ 0.00 | |
| ¥ -23.85M | ¥ -672.94M | ¥ 24.24M | ¥ -475.64M | ¥ -66.27M | |
| ¥ 223.91M | ¥ 278.26M | ¥ 896.33M | ¥ 1.88B | ¥ 2.17B | |
| Depreciation and Amortization | ¥ 26.52M | ¥ 40.32M | ¥ 74.74M | ¥ 56.62M | ¥ 24.49M |
| ¥ -221.24M | ¥ -914.52M | ¥ -45.07M | ¥ -2.34B | ¥ -2.21B | |
| ¥ -247.75M | ¥ -951.21M | ¥ -2.58B | ¥ -2.35B | ¥ -2.24B | |
| ¥ 47.97M | ¥ 47.78M | ¥ 2.44B | ¥ -100.70M | ¥ -3.78B | |
| ¥ -199.78M | ¥ -903.43M | ¥ -138.54M | ¥ -2.45B | ¥ -6.02B | |
| ¥ -199.78M | ¥ -903.43M | ¥ -138.54M | ¥ -2.45B | ¥ -6.02B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.16 | ¥ -0.72 | ¥ -0.11 | ¥ -2.22 | ¥ -5.37 |
| Diluted EPS | ¥ -0.16 | ¥ -0.72 | ¥ -0.11 | ¥ -2.22 | ¥ -5.36 |
| Weighted Average Shares Outstanding | 1.26B | 1.25B | 1.24B | 1.10B | 1.12B |
| Weighted Average Shares Outstanding (Diluted) | 1.26B | 1.25B | 1.24B | 1.10B | 1.12B |
Currency in CNY
